Education:

• 2018 - 2024: PhD degree in biology – specialized in membrane contact sites in phagocytosis, exocytosis and apoptosis. Obtained at Harald Stenmark Lab at Department of Molecular Cell Biology, Institute for Cancer Research (ICR), Oslo

• 2016 - 2018: Master of Science degree in cell and molecular biology - Specialization in cPLA2 inhibitors for breast cancer. Obtained at Berit Johansen Lab at NTNU Trondheim

• 2013 - 2016: Bachelor of Science degree in biology – Specialization in cell and molecular biology, NTNU Trondheim

Professional experience:

• February 2025 - Present: Postdoc in the Department of Cellular Therapy, Oslo University Hospital, Norway. Investigating CAR T-cells by using super resolution microscopy.

• December 2018 - December 2024: PhD candidate. Research Project: "Protrudin in Membrane Contact Sites Regulates Phagocytosis, Apoptosis and Exocytosis", Dept. Molecular Cell Biology in Camilla Raiborgs group, Institute for Cancer Research, Oslo, Norway. Also part of the InvaCell project, a cooperation between ICR in Oslo and Insitute Curie in Paris, France.

• June 2017 - August 2017 Internship in the life science company Avexxin (now Coegin Pharma), NTNU Trondheim, Norway. Investigated cPLA2 inhibitors in blood cancer cell lines.

Research interests/projects:

Developing and investigating safe CAR constructs, microscopy, immunotherapy, cell and molecular biology.